“Advancing Healthcare through Science & Innovation”
PT AstraZeneca is the top pharmaceutical company in Indonesia and it’s not just because its Covid-19 vaccine led the fight against the pandemic.
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that develops, manufactures and markets revolutionary treatments and biopharmaceuticals to address a wide range of diseases and medical conditions. Its areas of focus are oncology, chronic diseases, rare diseases, biopharmaceuticals and vaccines.
One of AstraZeneca’s major achievements is the development and launch of AZD1222 vaccines which played a critical role in addressing the Covid-19 pandemic. It became the most widely used vaccine in the world. In Indonesia, 107.4 million doses were delivered which helped prevent 93,954 deaths.
Later renamed Vaxzevria, the vaccine saved more than six million lives worldwide in the first year. AstraZeneca’s Evusheld, with its long-acting combination of antibodies, continues to help protect those most vulnerable to COVID-19.
What puts AstraZeneca at the Top
AstraZeneca Indonesia is the number one MNC Pharmaceutical Company in Indonesia according to IQVIA Market Data 2022. Its success is due to its ability to continually deliver life-changing and innovative medicines in the region, contributing significantly to the advancement in healthcare. There are additional factors and they are:
AstraZeneca’s People: In 2022, AstraZeneca empowered 83,500 employees in a dynamic, inclusive, and high-performing environment, including in Indonesia. They focused on coaching, development, and employee contribution and conducted 555 performance development workshops for 16,500 participants. The company also provided continuous recognition, giving 269,000 rewards to 68% of employees, with 20% being cross-functional. Women make up 52.9% (approximately 43,900) of their global workforce, and their Board comprises five women (38% of the total). An internal survey showed that 83% of AstraZeneca employees felt comfortable speaking up and expressing their opinions at work.
“Eastern Communications’ talent development and career advancement programmes are put in place to determine talents who are ready for next level, leadership roles or critical roles. The organization conducts a Talent Assessment, which determines readiness; and identifies development programs that the incumbent will need to achieve and be successful in the target position.”
Shanggari Balakrishnan, Chief Executive Officer, MORS Group